Form 4: ICU Medical Inc. Director George A. Lopez Sells Shares
SEC Form 4 Filing
Director George A. Lopez of ICU Medical Inc. reports the sale of common stock shares over three days in March 2024.
Summary
- George A. Lopez, a director at ICU Medical Inc., sold shares of common stock on March 4, 7, and 8, 2024.
- On March 4, 2024, Lopez sold 7,051 shares at a price of $106.7923 per share.
- On March 7, 2024, Lopez sold 18,954 shares at a price of $105.767 per share.
- On March 8, 2024, Lopez sold 15,372 shares at a price of $105.9364 per share.
- Following these transactions, Lopez directly owns 319,643 shares of common stock and indirectly owns 886,843 shares through a partnership.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions without expressing any opinion or outlook.
Industry Context
This is a routine disclosure of stock sales by a company insider, which is common and expected. It doesn't necessarily indicate a negative outlook for the company.
Stakeholder Impact
- The stock sales by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Sale of 7,051 shares of common stock at $106.7923 per share. |
| 03/07/2024 | Sale of 18,954 shares of common stock at $105.767 per share. |
| 03/08/2024 | Sale of 15,372 shares of common stock at $105.9364 per share. |
| 03/11/2024 | Date of signature by Paula Darbyshire, Attorney-in-fact, for George A. Lopez, M.D. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.